Brief: LianBio Completes Phase 1 Pharmacokinetic Study Of Mavacamten In Healthy Chinese Volunteers

LianBio

09/05/2022 13:17

May 9 (Reuters) - LianBio  LIAN.O :
    * LIANBIO COMPLETES PHASE 1 PHARMACOKINETIC STUDY OF
MAVACAMTEN IN
HEALTHY CHINESE VOLUNTEERS
    * LIANBIO - MAVACAMTEN DEMONSTRATED A FAVORABLE SAFETY,
TOLERABILITY AND PHARMACOKINETIC PROFILE IN HEALTHY CHINESE
VOLUNTEERS
    * LIANBIO - A SINGLE ORAL ADMINISTRATION OF MAVACAMTEN
SHOWED NO
NEW SAFETY SIGNALS IN CHINESE HEALTHY ADULT SUBJECTS

Source text for Eikon:  ID:nGNX4m7B2T 
Further company coverage:  LIAN.O 

 ((Reuters.Briefs@thomsonreuters.com;))